2. Introduction:
Curare alkaloids are the neuromuscular blocking agent
Agents that block the transmission of Ach at the motor end
plate
The therapeutic use of these compound is primarily as
adjuvants in surgical anesthesia to obtain relaxation of
skeletal muscles
Obtained from bark and steam of strychnos castelnoci and
strychnos toxifera, chondodendron tomentosum
South American Indians used curare as a very potent arrow
poison
Early preprations:
• Calabash (gourd)
• Tube (bamboo)
• Pot curare (clay pot)
5. Tubocurarine:
• By extraction
• Quaternary compound
• Contains bis-benzylisoquinoline structure
• Block the nicotinic receptor at neuromuscular junction
• Produce paralyzing effect on voluntary muscle
• Used as a diagnosis agent for myasthenia gravis
• Toxic action blood vessels
6. Tubocurarine chloride, USP:
• Prepare from crude curare
• by process of purification & crystallization
• Non-depolarizing blocking agent
• Block the nicotinic receptor at neuromuscular junction
• Physical property-
a. White or yellowish white to grayish white
b. Odourless
c. Crystalline powder
d. Soluble in water
7. Quaternary ammonium
Tertiary amine
In acidisis
+ charge increase potency
•SAR- Bis- quaternary ammonium compound having two quaternary
ammonium salts separated by 10-12 carbon atoms was required for
neuromuscular blocking activity
1o-12 carbon bridge between 2 nitrogen max. Neuromuscular blockade
8. • Use-
i. as a diagnosis agent for myasthenia gravis
ii. Skeletal muscle relaxant
iii. adjuvants in surgical anesthesia to obtain relaxation of
skeletal muscles
iv. Control convulsions of strychnine poisoning & of tetanus
• Side effect- hypotension, bronchoconstricion
• Drawback –
Incidence of bone & spine fractures & dislocations from
convulsions because of shock
9. Metocurine Iodide, USP:
(+)-O,O-dimethylchondrocurarine diiodide
• Prepared from natural crude curare
• By extracting the curare with methanolic pot. Hydroxide
• MOA same as a d-tubocurarine
• More potent than d-tubocurarine
10. • Excess of methyl iodide give metocurine iodide
• 2 phenolic hydroxyl group are methylated
11. Synthetic compounds with curariform activity
Atracurium Besylate:
2-(2-carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-
veratryl isoquinolinium benzenesulfonate pentamethylene ester
(Tracrium)
• Intermediate acting Non-depolarizing neuromuscular blocking
agent
• 2-5 time potent than d-tubocurarine
• Duration of action (30-40 min.) shorter than d-tubocurarine
• Metabolized rapidly
• Safe in hepatic & renal impairment
13. Gallamine Triethiodide, USP:
[v-phenenyl-tris(oxyethylene)]tris[triethylammonium]
triiodide(Flaxedil)
• MOA same as a d-tubocurarine
• Less potent than d-tubocurarine
• Shorter onset (2-3min) & longer duration (>2hr.) than d-
tubocurarine
• It also has muscarinic antagonistic activity
• Stronger vagolytic effect
• Side effect- tachycardia
• Contraindicated in myasthenia gravis & renal failure
• Antidote for gallamine triethiodide is neostigmine
14. Mivacurium chloride:
1,2,3,4-tetrahydro-2-(3-hydroxypropyl)-6,7-dimethoxy-2-
methyl-1-(3,4,5-trimethoxybenzyl)isoquinolinium chloride,
(E)-4-octandioate (Mivacron)
• Short acting non depolarizing drug
• Used as an adjunct to anesthesia to relax skeletal muscle
• Side effect – transient hypotension
15. Pancuronium bromide:
2,16-dipiperidino-5-androstane-3,17-diol diacetate
dimethobromide (Pavulon)
• Synthetic product
• Non depolarizing blocker
• Act on nicotinic receptor & in the ion channel, inhibiting
normal ion fluxes
• 6 time potent than d-tubocurarine
• Slow onset of action (4-6 min.)
• Longer duration of action (2-3 hr.)
• First steroid based compound
• Use- adjunct to anesthesia to induce relaxation of skeletal
muscles
• Side effect- tachycardia
19. Succinylcholine chloride, USP:
• Very short duration of action
• Unstable in alkaline solution & stable in acidic solution
• Quick recovery because its rapid hydrolysis after injection
• Suitable for continues iv drip administration